查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827770

2025年全球整形外科重建產品市場報告

Orthopedic Regenerative Surgical Products Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，整形外科重建產品市場呈現強勁成長勢頭，市場規模從2024年的45.4億美元增至2025年的48.8億美元，複合年成長率達7.5%。預測期內的成長主要受人口老化、整形外科損傷、病患需求、運動醫學和肌肉骨骼疾病等因素所驅動。

預計未來幾年整形外科​​重建手術產品市場規模將強勁成長，到2029年將達到68.4億美元，複合年成長率為8.8%。預測期內的成長歸因於監管核准、永續實踐、微創手術、復健和物理治療以及關節保護。預測期內的主要趨勢包括先進的生物材料、外科手術的進步、人工智慧 (AI) 和預測分析、再生醫學的進步以及整形外科植入。

整形外科骨科產品在治療各種肌肉骨骼疾病方面發揮重要作用，包括關節痛、痛風、關節缺損、纖維肌痛、骨關節炎、創傷、關節重建和其他整形外科損傷。這些產品在再生整形外科醫學中尤其重要，其中富血小板血漿 (PRP) 等非手術治療通常用於輔助癒合和修復影響關節、肌腱、韌帶和肌肉的肌肉骨骼損傷。

整形外科再生手術產品的主要類型包括同種異體移植、合成材料、細胞產品和黏性補充。同種異體移植是指在同一物種的不同基因個體之間進行組織移植。人體同種異體移植的例子包括脛骨前肌腱、冷凍股骨頭、冷凍乾燥骨碎片、脫礦骨基質 (DBM) 膩子、去細胞真皮和羊膜。這些再生產品在醫院、門診手術中心和其他醫療機構用於治療整形外科疾病，包括疼痛管理、創傷修復、軟骨和肌腱修復以及關節重組。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供整形外科重建產品市場統計數據，包括全球市場規模、區域佔有率、整形外科重建產品市場佔有率競爭對手、詳細的整形外科重建產品細分市場、市場趨勢和商業機會，以及在整形外科重建產品整形外科取得成功所需的數據。本整形外科重建產品市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.8%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這種影響將透過對主要來自韓國和瑞士的生物工程組織和生長因子徵收關稅直接影響美國，這可能會增加先進軟骨修復和骨再生手術的成本。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

全球整形外科疾病盛行率的不斷上升預計將推動整形外科再生產品市場的成長。這些產品有助於預防骨折、扭傷和拉傷等整形外科問題，並管理導致功能受限和殘疾的終身疾病。例如，澳洲統計局2024年6月的報告顯示，到2023年，肌肉骨骼疾病將佔總疾病負擔（DALY）的12.8%，佔非致命性年度死亡人數（YLD）的23.1%，佔致命性年度死亡人數（YLL）的0.8%。到2022年，這些疾病將成為10,446例死亡（每10萬人口中有40例）的潛在或相關原因，佔所有死亡人數的5.5%。因此，整形外科疾病發生率的不斷上升正在推動對整形外科再生產品的需求。

預計整形外科重建產品市場的成長將由醫院數量的增加所推動。作為醫療機構，醫院在為病人和傷者提供治療、護理和服務方面至關重要。醫院採用整形外科重建產品可以改善患者預後、降低併發症風險、加速癒合和康復，並提供先進的重建手術選擇。截至 2023 年 5 月，美國醫院協會 (AHA) 報告稱，醫院總數從 2022 年的 6,093 家增加到 6,129 家，所有美國醫院的住院總人數達到 34,011,386 人次，高於上一年的 33,356,853 人次。因此，醫院數量的增加是推動整形外科重建產品市場擴張的關鍵因素。

技術進步已成為整形外科再生手術產品市場的關鍵趨勢。例如，2022年5月，美國生物製藥公司Ocugen Inc.宣布推出NeoCart，這是一項處於3期臨床階段的細胞治療平台技術（自體軟骨細胞衍生的新生軟骨）。 NeoCart最近獲得了美國食品藥物管理局（FDA）頒發的再生醫學先進療法（RMAT）認證，用於治療成人膝關節軟骨全層病變。

為了推動市場收益，整形外科重建手術市場的主要企業正策略性地專注於非永久性骨纖維壓縮釘等創新產品。這些醫療設備用於整形外科和肌肉骨骼手術中的骨折固定和骨癒合，提供臨時穩定性和壓迫以支持癒合和融合。例如，專門從事整形外科和肌肉骨骼應用的美國公司 Ossiofiber Inc. 於 2023 年 2 月推出了非永久性 Ossiofiber 壓縮釘。這種釘子結合了機械強度和自發性骨再生能力，為傳統植入（如可吸收或同種異體植入物和永久性金屬硬體）提供了替代方案。 Ossiofiber 壓縮釘為各種中足和後足手術提供解決方案，包括扁平足矯正術、Lapidus 固定和中足融合。

2022年4月，專注於骨生物技術和細胞療法的美國公司Isto Biologics收購了TheraCell，收購金額未揭露。此次收購旨在增強Isto Biologics在脊椎、整形外科和運動醫學領域的外科和臨床護理解決方案組合。 TheraCell是一家美國再生醫學公司，專注於開發用於骨骼修復和組織再生的創新產品。

整形外科再生手術產品市場的主要企業包括 Baxter International Inc.、Zimmer Biomet Holdings Inc.、Stryker Corporation、Smith & Nephew plc、Allosource、Anika Therapeutics Inc.、Vericel Corporation、Amniox Medical Inc.、MIMEDX Group Inc.、Aptissen SA、Art； LifeSciences Corporation、Johnson & Johnson Medical Devices group、Kuros Biosciences AG、Medtronic plc、NuVasive Inc.、Orthofix Medical Inc.、Osiris Therapeutics Inc.、RTI Surgical Inc.、SeaSpine Holdings Corporation、Terumo BCT Inc.、Tissue Rerights Inc.t. Spine Inc.、CollPlant Biotechnologies Ltd.等。

預計到2024年，北美將成為整形外科重建產品市場最大的地區，並有望成為預測期內成長最快的地區。整形外科重建產品市場分析報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

整形外科重建手術產品市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

整形外科重建產品市場包括同種異體骨楔、allowrap DS、BIO4、DBM、水凝固劑、吸收劑、神經修復和軟骨再生 (prochondrix CR)。該市場的價值是指“出廠價”，即產品製造商或創造者銷售給其他營業單位（包括下游製造商、經銷商、分銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球整形外科重建外科產品：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球整形外科重建產品市場：成長率分析
  • 全球整形外科重建產品市場表現：規模與成長，2019-2024
  • 全球整形外科重建產品市場預測：規模與成長，2024-2029年，2034年
  • 全球整形外科重建產品：總目標市場（TAM）

第6章 市場細分

  • 全球整形外科重建手術產品市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 同種異體移植
  • 合成
  • 基於細胞
  • 黏稠補充劑
  • 全球整形外科重建產品市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 整形外科疼痛管理
  • 創傷修復
  • 軟骨和肌腱修復
  • 關節重組
  • 全球整形外科重建產品市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 其他最終用戶
  • 全球整形外科重建產品市場：按同種異體移植、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 同種異體骨移植
  • 軟組織同種異體移植
  • 骨誘導同種異體移植
  • 骨傳導同種異體移植
  • 全球整形外科重建產品市場：按類型、成長和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 合成骨移植
  • 合成軟組織移植
  • 複合合成移植物
  • 全球整形外科再生醫學產品市場​​：按細胞類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 幹細胞療法
  • 富血小板血漿（PRP）
  • 間質幹細胞（MSCs）
  • 全球整形外科重建產品市場：黏性補充劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 玻尿酸注射
  • 透明質酸鈉
  • 其他濃稠補充劑產品

第7章 區域和國家分析

  • 全球整形外科重建產品市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球整形外科重建產品市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 整形外科再生手術產品市場：競爭格局
  • 整形外科重建產品市場：公司簡介
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • Allosource Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Anika Therapeutics Inc.
  • Vericel Corporation
  • Amniox Medical Inc.
  • MIMEDX Group Inc.
  • Aptissen SA
  • Arthrex Inc.
  • Bioventus LLC
  • Conmed Corporation
  • DePuy Synthes Inc.
  • Exactech Inc.
  • Globus Medical Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Medical Devices group
  • Kuros Biosciences AG
  • Medtronic plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年整形外科重建產品市場：提供新機會的國家
  • 2029 年整形外科重建產品市場：細分市場將帶來新機會
  • 2029 年整形外科重建產品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21893u

Orthopedic regenerative surgical products play a crucial role in treating various musculoskeletal conditions, including joint pains, gout, articular defects, fibromyalgia, osteoarthritis, trauma, joint replacement, and other orthopedic injuries. These products are particularly significant in regenerative orthopedic medicine, where nonsurgical treatments like platelet-rich plasma (PRP) are often chosen to aid in the healing and repair of musculoskeletal injuries, such as those affecting joints, tendons, ligaments, and muscles.

The main types of orthopedic regenerative surgical products include allografts, synthetic materials, cell-based products, and viscosupplements. Allografts involve the transplantation of tissue between genetically distinct individuals of the same species. Examples of human allografts include anterior tibialis tendon, frozen femoral head, freeze-dried bone chips, demineralized bone matrix (DBM) putty, acellular dermis, and amniotic membrane. These regenerative products are utilized by hospitals, ambulatory surgical centers, and other healthcare facilities for the treatment of orthopedic conditions such as pain management, trauma repair, cartilage and tendon repair, and joint reconstruction.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The orthopedic regenerative surgical products market research report is one of a series of new reports from The Business Research Company that provides orthopedic regenerative surgical products market statistics, including orthopedic regenerative surgical products industry global market size, regional shares, competitors with an orthopedic regenerative surgical products market share, detailed orthopedic regenerative surgical products market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic regenerative surgical products industry. This orthopedic regenerative surgical products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthopedic regenerative surgical products market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to aging population, orthopedic injuries, patient demand, sports medicine, musculoskeletal disorders.

The orthopedic regenerative surgical products market size is expected to see strong growth in the next few years. It will grow to $6.84 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to regulatory approval, sustainable practices, minimally invasive procedures, rehabilitation and physicalTherapy, joint preservation. Major trends in the forecast period include advanced biomaterials, surgical advancements, artificial intelligence (ai) and predictive analytics, regenerative medicine advancements, orthopedic implants.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on bioengineered tissues and growth factors, largely sourced from South Korea and Switzerland, raising expenses for advanced cartilage repair and bone regeneration procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of orthopedic diseases worldwide is expected to drive the growth of the orthopedic regenerative surgical products market. These products help prevent orthopedic issues such as fractures, sprains, and strains, as well as manage lifelong conditions that cause functional limitations and disabilities. For example, in June 2024, a report by the Australian Bureau of Statistics, an Australia-based statistical agency, revealed that musculoskeletal conditions accounted for 12.8% of the total disease burden (DALY), 23.1% of the non-fatal burden (YLD), and 0.8% of the fatal burden (YLL) in 2023. In 2022, these conditions were the underlying or associated cause of 10,446 deaths (40 per 100,000 population), representing 5.5% of all deaths. Therefore, the rising incidence of orthopedic diseases is driving the demand for orthopedic regenerative surgical products.

The anticipated growth of the orthopedic regenerative surgical products market is expected to be propelled by the increasing number of hospitals. Hospitals, as healthcare institutions, are essential in providing medical treatment, care, and services to individuals who are ill or injured. The adoption of orthopedic regenerative surgical products in hospitals is associated with enhanced patient outcomes, reduced risk of complications, faster healing and recovery, and the availability of advanced regenerative surgical options. As of May 2023, the American Hospital Association (AHA) reported an increase in the total number of hospitals to 6,129 compared to 6,093 in 2022, with total admissions across all U.S. hospitals reaching 34,011,386 compared to 33,356,853 in the previous year. Therefore, the growing number of hospitals is a significant factor driving the expansion of the orthopedic regenerative surgical products market.

Technological advancements are emerging as a key trend in the orthopedic regenerative surgical products market. For example, in May 2022, Ocugen Inc., a U.S.-based biopharmaceutical company, introduced NeoCart, a Phase 3 cell therapy platform technology (autologous chondrocyte-derived neocartilage). NeoCart recently received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for the treatment of full-thickness lesions in adult knee cartilage.

Major companies in the orthopedic regenerative surgical products market are strategically focusing on innovative products like the non-permanent ossiofiber compression staple to drive market revenues. This medical device is utilized in orthopedic and musculoskeletal surgeries for fracture fixation and bone fusion, providing temporary stability and compression to support healing and fusion. For instance, Ossio Inc., a US-based company specializing in orthopedic and musculoskeletal applications, launched the non-permanent ossiofiber compression staple in February 2023. Combining mechanical strength and spontaneous bone regeneration, this staple offers an alternative to traditional implants, such as resorbable and allograft options, as well as permanent metal hardware. Ossiofiber Compression Staples provide solutions for various midfoot and hindfoot procedures, including flatfoot corrective procedures, Lapidus fusions, and midfoot fusions.

In April 2022, Isto Biologics, a US-based company specializing in osteobiologic regeneration technologies and cell-based therapeutics, acquired TheraCell Inc. for an undisclosed sum. The acquisition aims to strengthen Isto Biologics' portfolio of surgical and clinical care solutions in the areas of spine, orthopedics, and sports medicine. TheraCell, Inc., a U.S.-based regenerative medicine company, focuses on developing innovative products for bone repair and tissue regeneration.

Major companies operating in the orthopedic regenerative surgical products market include Baxter International Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Smith&Nephew plc, Allosource, Anika Therapeutics Inc., Vericel Corporation, Amniox Medical Inc., MIMEDX Group Inc., Aptissen S.A, Arthrex Inc., Bioventus LLC, Conmed Corporation, DePuy Synthes Inc., Exactech Inc., Globus Medical Inc., Integra LifeSciences Corporation, Johnson & Johnson Medical Devices group, Kuros Biosciences AG, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Osiris Therapeutics Inc., RTI Surgical Inc., SeaSpine Holdings Corporation, Terumo BCT Inc., Tissue Regenix Group plc, Wright Medical Group N.V., Xtant Medical Holdings Inc., Camber Spine Technologies, Lima Corporate, Life Spine Inc., CollPlant Biotechnologies Ltd.

North America was the largest region in the orthopedic regenerative surgical products market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic regenerative surgical products market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the orthopedic regenerative surgical products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The orthopedic regenerative surgical products market consists of sales of allograft wedges, allowrap DS, BIO4, DBM, hydroset, imbibe, nerve repair, and prochondrix CR.Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthopedic Regenerative Surgical Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthopedic regenerative surgical products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthopedic regenerative surgical products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthopedic regenerative surgical products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Allograft, Synthetic, Cell-based, Viscosupplements
  • 2) By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction
  • 3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
  • Subsegments:
  • 1) By Allograft: Bone Allograft; Soft Tissue Allograft; Osteoinductive Allograft; Osteoconductive Allograft
  • 2) By Synthetic: Synthetic Bone Grafts; Synthetic Soft Tissue Grafts; Composite Synthetic Grafts
  • 3) By Cell-based: Stem Cell Therapies; Platelet-Rich Plasma (PRP); Mesenchymal Stem Cells (MSCs)
  • 4) By Viscosupplements: Hyaluronic Acid Injections; Sodium Hyaluronate; Other Viscosupplement Products
  • Companies Mentioned: Baxter International Inc.; Zimmer Biomet Holdings Inc.; Stryker Corporation; Smith&Nephew plc; Allosource; Anika Therapeutics Inc.; Vericel Corporation; Amniox Medical Inc.; MIMEDX Group Inc.; Aptissen S.A; Arthrex Inc.; Bioventus LLC; Conmed Corporation; DePuy Synthes Inc.; Exactech Inc.; Globus Medical Inc.; Integra LifeSciences Corporation; Johnson & Johnson Medical Devices group; Kuros Biosciences AG; Medtronic plc; NuVasive Inc.; Orthofix Medical Inc.; Osiris Therapeutics Inc.; RTI Surgical Inc.; SeaSpine Holdings Corporation; Terumo BCT Inc.; Tissue Regenix Group plc; Wright Medical Group N.V.; Xtant Medical Holdings Inc.; Camber Spine Technologies; Lima Corporate; Life Spine Inc.; CollPlant Biotechnologies Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orthopedic Regenerative Surgical Products Market Characteristics

3. Orthopedic Regenerative Surgical Products Market Trends And Strategies

4. Orthopedic Regenerative Surgical Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Orthopedic Regenerative Surgical Products Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Orthopedic Regenerative Surgical Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Orthopedic Regenerative Surgical Products Market Growth Rate Analysis
  • 5.4. Global Orthopedic Regenerative Surgical Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Orthopedic Regenerative Surgical Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Orthopedic Regenerative Surgical Products Total Addressable Market (TAM)

6. Orthopedic Regenerative Surgical Products Market Segmentation

  • 6.1. Global Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allograft
  • Synthetic
  • Cell-based
  • Viscosupplements
  • 6.2. Global Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Orthopedic Pain Management
  • Trauma Repair
  • Cartilage and Tendon Repair
  • Joint Reconstruction
  • 6.3. Global Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.4. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Allograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Allograft
  • Soft Tissue Allograft
  • Osteoinductive Allograft
  • Osteoconductive Allograft
  • 6.5. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Bone Grafts
  • Synthetic Soft Tissue Grafts
  • Composite Synthetic Grafts
  • 6.6. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Cell-based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapies
  • Platelet-Rich Plasma (PRP)
  • Mesenchymal Stem Cells (MSCs)
  • 6.7. Global Orthopedic Regenerative Surgical Products Market, Sub-Segmentation Of Viscosupplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyaluronic Acid Injections
  • Sodium Hyaluronate
  • Other Viscosupplement Products

7. Orthopedic Regenerative Surgical Products Market Regional And Country Analysis

  • 7.1. Global Orthopedic Regenerative Surgical Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Orthopedic Regenerative Surgical Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orthopedic Regenerative Surgical Products Market

  • 8.1. Asia-Pacific Orthopedic Regenerative Surgical Products Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orthopedic Regenerative Surgical Products Market

  • 9.1. China Orthopedic Regenerative Surgical Products Market Overview
  • 9.2. China Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orthopedic Regenerative Surgical Products Market

  • 10.1. India Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orthopedic Regenerative Surgical Products Market

  • 11.1. Japan Orthopedic Regenerative Surgical Products Market Overview
  • 11.2. Japan Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orthopedic Regenerative Surgical Products Market

  • 12.1. Australia Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orthopedic Regenerative Surgical Products Market

  • 13.1. Indonesia Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orthopedic Regenerative Surgical Products Market

  • 14.1. South Korea Orthopedic Regenerative Surgical Products Market Overview
  • 14.2. South Korea Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orthopedic Regenerative Surgical Products Market

  • 15.1. Western Europe Orthopedic Regenerative Surgical Products Market Overview
  • 15.2. Western Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orthopedic Regenerative Surgical Products Market

  • 16.1. UK Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orthopedic Regenerative Surgical Products Market

  • 17.1. Germany Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orthopedic Regenerative Surgical Products Market

  • 18.1. France Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orthopedic Regenerative Surgical Products Market

  • 19.1. Italy Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orthopedic Regenerative Surgical Products Market

  • 20.1. Spain Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orthopedic Regenerative Surgical Products Market

  • 21.1. Eastern Europe Orthopedic Regenerative Surgical Products Market Overview
  • 21.2. Eastern Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orthopedic Regenerative Surgical Products Market

  • 22.1. Russia Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orthopedic Regenerative Surgical Products Market

  • 23.1. North America Orthopedic Regenerative Surgical Products Market Overview
  • 23.2. North America Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orthopedic Regenerative Surgical Products Market

  • 24.1. USA Orthopedic Regenerative Surgical Products Market Overview
  • 24.2. USA Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orthopedic Regenerative Surgical Products Market

  • 25.1. Canada Orthopedic Regenerative Surgical Products Market Overview
  • 25.2. Canada Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orthopedic Regenerative Surgical Products Market

  • 26.1. South America Orthopedic Regenerative Surgical Products Market Overview
  • 26.2. South America Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orthopedic Regenerative Surgical Products Market

  • 27.1. Brazil Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orthopedic Regenerative Surgical Products Market

  • 28.1. Middle East Orthopedic Regenerative Surgical Products Market Overview
  • 28.2. Middle East Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orthopedic Regenerative Surgical Products Market

  • 29.1. Africa Orthopedic Regenerative Surgical Products Market Overview
  • 29.2. Africa Orthopedic Regenerative Surgical Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Orthopedic Regenerative Surgical Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Orthopedic Regenerative Surgical Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orthopedic Regenerative Surgical Products Market Competitive Landscape And Company Profiles

  • 30.1. Orthopedic Regenerative Surgical Products Market Competitive Landscape
  • 30.2. Orthopedic Regenerative Surgical Products Market Company Profiles
    • 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Smith & Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Allosource Overview, Products and Services, Strategy and Financial Analysis

31. Orthopedic Regenerative Surgical Products Market Other Major And Innovative Companies

  • 31.1. Anika Therapeutics Inc.
  • 31.2. Vericel Corporation
  • 31.3. Amniox Medical Inc.
  • 31.4. MIMEDX Group Inc.
  • 31.5. Aptissen S.A.
  • 31.6. Arthrex Inc.
  • 31.7. Bioventus LLC
  • 31.8. Conmed Corporation
  • 31.9. DePuy Synthes Inc.
  • 31.10. Exactech Inc.
  • 31.11. Globus Medical Inc.
  • 31.12. Integra LifeSciences Corporation
  • 31.13. Johnson & Johnson Medical Devices group
  • 31.14. Kuros Biosciences AG
  • 31.15. Medtronic plc

32. Global Orthopedic Regenerative Surgical Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Orthopedic Regenerative Surgical Products Market

34. Recent Developments In The Orthopedic Regenerative Surgical Products Market

35. Orthopedic Regenerative Surgical Products Market High Potential Countries, Segments and Strategies

  • 35.1 Orthopedic Regenerative Surgical Products Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Orthopedic Regenerative Surgical Products Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Orthopedic Regenerative Surgical Products Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer